Apellis Pharmaceuticals, Inc.APLSNASDAQ
Loading
Year-over-year revenue growth rate
Percentile
P10
Near historical low
vs 5Y Ago
0x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -56.41% |
| Q3 2025 | 156.92% |
| Q2 2025 | 7.01% |
| Q1 2025 | -21.52% |
| Q4 2024 | 7.98% |
| Q3 2024 | -1.43% |
| Q2 2024 | 15.88% |
| Q1 2024 | 17.73% |
| Q4 2023 | 32.59% |
| Q3 2023 | 16.25% |
| Q2 2023 | 111.77% |
| Q1 2023 | 97.88% |
| Q4 2022 | 2.75% |
| Q3 2022 | 35.13% |
| Q2 2022 | 13.50% |
| Q1 2022 | -76.15% |
| Q4 2021 | 967.08% |
| Q3 2021 | 806.90% |
| Q2 2021 | 0.00% |
| Q1 2021 | -100.00% |
| Q4 2020 | 38599.69% |
| Q3 2020 | 0.00% |
| Q2 2020 | 0.00% |
| Q1 2020 | 0.00% |
| Q4 2019 | 0.00% |
| Q3 2019 | 0.00% |
| Q2 2019 | 0.00% |
| Q1 2019 | -100.00% |
| Q4 2018 | 0.00% |
| Q3 2018 | 0.00% |
| Q2 2018 | 0.00% |
| Q1 2018 | -100.00% |
| Q4 2017 | 0.00% |
| Q3 2017 | 0.00% |
| Q2 2017 | 0.00% |
| Q1 2017 | 0.00% |
| Q4 2016 | 0.00% |
| Q3 2016 | 0.00% |
| Q2 2016 | 0.00% |
| Q1 2016 | 0.00% |